Download Files:
Ozagrel (sodium)
$38 – $220
Products Details
Product Description
– Ozagrel sodium (OKY-046 sodium) is a thromboxane A2 (TXA2) synthase inhibitor. Ozagrel sodium is an antiplatelet agent, which selectively inhibits human platelet aggregation with an IC50 of 53.12 μM[1].
Web ID
– HY-B0428A
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C13H11N2NaO2
References
– [1]Max Seidy Saito, et al. Antiplatelet pyrazolopyridines derivatives: pharmacological, biochemical and toxicological characterization. J Enzyme Inhib Med Chem. 2016 Dec;31(6):1591-601.
CAS Number
– 189224-26-8
Molecular Weight
– 250.23
Compound Purity
– 99.98
SMILES
– O=C(O[Na])/C=C/C1=CC=C(CN2C=CN=C2)C=C1
Clinical Information
– Launched
Research Area
– Cardiovascular Disease
Solubility
– DMSO : 6.25 mg/mL (ultrasonic)|H2O : 50 mg/mL (ultrasonic)
Target
– Prostaglandin Receptor
Isoform
– TXA2/TP
Pathway
– GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
